EUVIMEDEUVIMED entdecken
Crossref

Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing

Larisa H. Cavallari, Victoria M. Pratt

Advances in Molecular Pathology · 2018

DOI: 10.1016/j.yamp.2018.06.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Molecular Pathology, 2018. Verfasst von Larisa H. Cavallari und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NHGRI, NCATS, NIH/NHGRI.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • NHGRI
  • NCATS
  • NIH/NHGRI
  • Indiana University Health – Indiana University School of Medicine Strategic Research Initiative
  • Indiana University School of Medicine Pharmacogenomics Laboratory

Zitieren

APA

Cavallari, L. H., & Pratt, V. M. (2018). Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing. Advances in Molecular Pathology. https://doi.org/10.1016/j.yamp.2018.06.008

Vancouver

Cavallari LH, Pratt VM. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing. Advances in Molecular Pathology. 2018. doi:10.1016/j.yamp.2018.06.008

BibTeX
@article{Cavallari2018,
  author = {Cavallari, Larisa H. and Pratt, Victoria M.},
  title = {Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing},
  journal = {Advances in Molecular Pathology},
  year = {2018},
  doi = {10.1016/j.yamp.2018.06.008}
}
Kostenlos starten →